CRUSHMETRIC Group Limited

OFEX:CUSH Stock Report

Market Cap: UK£30.0m

CRUSHMETRIC Group Past Earnings Performance

Past criteria checks 0/6

CRUSHMETRIC Group has been growing earnings at an average annual rate of 18.2%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been declining at an average rate of 13.8% per year.

Key information

18.2%

Earnings growth rate

41.6%

EPS growth rate

Healthcare Industry Growth12.6%
Revenue growth rate-13.8%
Return on equity-36.8%
Net Margin-972.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How CRUSHMETRIC Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OFEX:CUSH Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 237-67120
31 Dec 2211-6110
30 Sep 2210-4100
30 Jun 229-290
31 Mar 227-4100
31 Dec 215-5120
30 Sep 2187150
30 Jun 211020190
31 Mar 211514260
31 Dec 20209330
30 Sep 2022-12390
30 Jun 2024-33450
31 Mar 2020-35450
31 Dec 1915-38450
30 Sep 1913-34400
30 Jun 1912-30350
31 Mar 1911-32380
31 Dec 1811-35410
30 Sep 1810-37390
30 Jun 1810-38380
31 Mar 1811-28280
31 Dec 1712-17180
30 Sep 1712-14180
30 Jun 1713-12180
31 Mar 1712-12180
31 Dec 1611-11170
30 Sep 1610-13160
30 Jun 169-14140
31 Mar 169-15160
31 Dec 158-17170
30 Sep 159-14180
30 Jun 1510-11180
31 Mar 1513-8160
31 Dec 1415-5140
30 Sep 1416-3140
30 Jun 1417-2130
31 Mar 1418-2130
31 Dec 1318-1130

Quality Earnings: CUSH is currently unprofitable.

Growing Profit Margin: CUSH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CUSH is unprofitable, but has reduced losses over the past 5 years at a rate of 18.2% per year.

Accelerating Growth: Unable to compare CUSH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CUSH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.2%).


Return on Equity

High ROE: CUSH has a negative Return on Equity (-36.75%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies